Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Sagimet Biosciences Inc. (SGMT) had Non-Operating Income/Expense of $5.85M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-51.04M |
|
-- |
|
-- |
|
$56.89M |
|
$-56.89M |
|
|
Non-Operating Income/Expense |
$5.85M |
$-51.04M |
|
$-51.04M |
|
$-51.04M |
|
$-51.04M |
|
$-51.04M |
|
$-51.04M |
|
$-56.89M |
|
$-57.28M |
|
32.35M |
|
32.35M |
|
$-1.58 |
|
$-1.58 |
|
| Balance Sheet Financials | |
$116.40M |
|
-- |
|
$0.08M |
|
$116.48M |
|
$5.10M |
|
-- |
|
-- |
|
$5.10M |
|
$111.38M |
|
$111.38M |
|
$111.38M |
|
32.52M |
|
| Cash Flow Statement Financials | |
$-45.65M |
|
$4.56M |
|
$0.28M |
|
$75.84M |
|
$35.02M |
|
$-40.82M |
|
$6.45M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
22.82 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-45.65M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-45.82% |
|
-45.82% |
|
-43.82% |
|
-45.82% |
|
$3.42 |
|
$-1.41 |
|
$-1.41 |
|